We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,175.00
Bid: 11,100.00
Ask: 11,250.00
Change: -25.00 (-0.22%)
Spread: 150.00 (1.351%)
Open: 11,150.00
High: 11,200.00
Low: 11,150.00
Prev. Close: 11,200.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Korvus Technology Ltd

19 Oct 2020 07:00

RNS Number : 4005C
Judges Scientific PLC
19 October 2020
 

 

 

Press Release

19 October 2020

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Acquisition of Korvus Technology Ltd

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces it has acquired the entire issued share capital of Korvus Technology Limited ("Korvus" or the "Acquisition"), a maker of vapour deposition systems. The Board expects the Acquisition to be immediately earnings enhancing. 

 

The initial consideration for Korvus is £2.64 million in cash. The consideration for the Acquisition has been financed from the Group's £35 million acquisition facility from Lloyds Bank Corporate Markets.

 

Information and rationale for the Acquisition

 

Korvus specialises in the design and manufacture of vapour deposition systems used to coat materials with thin films. Korvus' systems are used for academic and industrial research, the majority of sales being to universities. Korvus' systems are particularly versatile with their modular hexagonal design, enabling the users to easily create a combination of accessories to meet their research requirements.

 

Korvus, based in Tavistock, Devon, was established in 2015 by Dr Lars and Philippa Allers; they will continue in their current roles until March 2021. From April 2021 to March 2025, Dr Allers will act for Korvus as a consultant, predominantly to help with new product development and strategy.

 

Korvus' statutory accounts for the financial year to 31 March 2020 show revenues of £1.42 million and pre-tax profits of £0.74 million. Net tangible assets amounted to £0.68 million, including cash of £0.16 million. Korvus' operating profit for the year ended 31 March 2020, adjusted to eliminate non-recurring items and to reflect Korvus' ongoing cost base within Judges, would have totalled £0.66 million. 

 

The Acquisition will add to the Group's capability in thin films alongside Quorum and Moorfield.

 

Terms of the Acquisition

 

The purchase price of Korvus consists of the following:

· The initial consideration, paid in cash at completion, amounts to £2.64 million;

· Deferred consideration of up to £0.4 million ("Earn-out Consideration") to be satisfied in cash.

 

The level of Earn-out Consideration payable will be based on Korvus' adjusted EBIT in the year to 31 March 2021.

 

An additional payment will be made to reflect any excess cash balances over and above the ongoing requirements of the business. The Board expects such payment to be covered by the cash inherited at the completion date.

Alex Hambro, Chairman of Judges, said:

"Korvus is an excellent company with innovative products, which will complement Judges' already strong capabilities in the coating sector, and we are looking forward to working with Phillipa and Lars towards a smooth transition. This cash generative acquisition, which is the third in the past eleven months, will enhance our earnings in accordance with our disciplined acquisition strategy and further demonstrates the resilience of our buy and build model."

 

For further information please contact:

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

 

Liberum (Joint Broker)

 

Bidhi Bhoma

Euan Brown

 

 

 

Tel: +44 (0) 20 3100 2222

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Rebecca Sanders-Hewett

Sam Modlin

 

Tel: +44 (0) 20 3865 4219

judges@almapr.co.uk

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 19 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export. 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends. 

For further information, please visit www.judges.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBRBDGXGBDGGI
Date   Source Headline
22nd Jul 20147:00 amRNSDirector/PDMR Shareholding
18th Jul 20143:14 pmRNSHolding(s) in Company
17th Jul 20147:00 amRNSTrading Statement
9th Jul 20145:24 pmRNSDirector/PDMR Shareholding
6th Jun 20143:52 pmRNSDirector/PDMR Shareholding
5th Jun 201412:03 pmRNSIssue of Equity
3rd Jun 20144:15 pmRNSDirector/PDMR Shareholding
23rd May 20143:20 pmRNSExercise of options
22nd May 20147:00 amRNSPayment of deferred consideration for Scientifica
19th May 20143:08 pmRNSExercise of options
12th May 20141:54 pmRNSDirector/PDMR Shareholding
24th Apr 20145:30 pmRNSExercise of Options
10th Apr 201412:01 pmRNSExercise of options
8th Apr 20146:15 pmRNSDirector/PDMR Shareholding
4th Apr 20142:28 pmRNSExercise of Options
28th Mar 20147:00 amRNSFinal Results
10th Mar 201410:00 amRNSNotice of Results
10th Mar 20148:51 amRNSDirector/PDMR Shareholding
7th Feb 20142:53 pmRNSDirector/PDMR Shareholding
24th Jan 20147:00 amRNSTrading Statement
22nd Jan 20142:01 pmRNSExercise of Options
13th Jan 20141:40 pmRNSHolding(s) in Company
10th Jan 20146:00 pmRNSHolding(s) in Company
9th Jan 20144:34 pmRNSDirector/PDMR Shareholding
13th Dec 201310:31 amRNSIssue of Equity
10th Dec 20138:39 amRNSDirector/PDMR Shareholding
4th Dec 20134:06 pmRNSIssue of Equity
26th Nov 20133:31 pmRNSDirector/PDMR Shareholding
20th Nov 20137:00 amRNSTrading Statement
7th Nov 20132:04 pmRNSDirector/PDMR Shareholding
25th Oct 20135:24 pmRNSHolding(s) in Company
25th Oct 20134:19 pmRNSDirector/PDMR Shareholding
21st Oct 20137:00 amRNSPlacing to raise GBP8.125 million
9th Oct 20131:25 pmRNSDirector/PDMR Shareholding
2nd Oct 20135:47 pmRNSHolding(s) in Company
26th Sep 20137:00 amRNSHalf Yearly Report
17th Sep 20134:17 pmRNSNotice of Results
9th Sep 20134:15 pmRNSDirector/PDMR Shareholding
13th Aug 201312:48 pmRNSHolding(s) in Company
6th Aug 20134:33 pmRNSDirector/PDMR Shareholding
18th Jul 20132:04 pmRNSDirector/PDMR Shareholding
18th Jul 20137:00 amRNSTrading Statement
15th Jul 20134:59 pmRNSExercise of Options
10th Jul 20131:27 pmRNSExercise of options
9th Jul 20137:00 amRNSDirector/PDMR Shareholding and Issue of Equity
27th Jun 20134:52 pmRNSHolding(s) in Company
27th Jun 20137:00 amRNSAcquisition and Trading Update
7th Jun 20133:24 pmRNSDirector/PDMR Shareholding
29th May 20135:17 pmRNSResult of AGM
10th May 20134:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.